Papke RL - Search Results

1

Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Papke RL, Horenstein NA. Papke RL, et al. Pharmacol Rev. 2021 Jul;73(3):1118-1149. doi: 10.1124/pharmrev.120.000097. Pharmacol Rev. 2021. PMID: 34301823 Free PMC article. Review.

2

A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus.

Hunter BE, de Fiebre CM, Papke RL, Kem WR, Meyer EM. Hunter BE, et al. Among authors: papke rl. Neurosci Lett. 1994 Feb 28;168(1-2):130-4. doi: 10.1016/0304-3940(94)90433-2. Neurosci Lett. 1994. PMID: 8028765

3

An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype.

Papke RL, Bencherif M, Lippiello P. Papke RL, et al. Neurosci Lett. 1996 Aug 9;213(3):201-4. doi: 10.1016/0304-3940(96)12889-5. Neurosci Lett. 1996. PMID: 8873149

4

Activation and inhibition of rat neuronal nicotinic receptors by ABT-418.

Papke RL, Thinschmidt JS, Moulton BA, Meyer EM, Poirier A. Papke RL, et al. Br J Pharmacol. 1997 Feb;120(3):429-38. doi: 10.1038/sj.bjp.0700930. Br J Pharmacol. 1997. PMID: 9031746 Free PMC article.

5

Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties.

Meyer EM, Tay ET, Zoltewicz JA, Meyers C, King MA, Papke RL, De Fiebre CM. Meyer EM, et al. Among authors: papke rl. J Pharmacol Exp Ther. 1998 Mar;284(3):1026-32. J Pharmacol Exp Ther. 1998. PMID: 9495863

6

The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.

Papke RL, Thinschmidt JS. Papke RL, et al. Neurosci Lett. 1998 Nov 13;256(3):163-6. doi: 10.1016/s0304-3940(98)00786-1. Neurosci Lett. 1998. PMID: 9855365

7

Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.

Meyer EM, Kuryatov A, Gerzanich V, Lindstrom J, Papke RL. Meyer EM, et al. Among authors: papke rl. J Pharmacol Exp Ther. 1998 Dec;287(3):918-25. J Pharmacol Exp Ther. 1998. PMID: 9864273

8

The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype.

Papke RL, Webster JC, Lippiello PM, Bencherif M, Francis MM. Papke RL, et al. J Neurochem. 2000 Jul;75(1):204-16. doi: 10.1046/j.1471-4159.2000.0750204.x. J Neurochem. 2000. PMID: 10854263 Free article.

9

Inhibition of wild-type and mutant neuronal nicotinic acetylcholine receptors by local anesthetics.

Papke RL, Horenstein BA, Placzek AN. Papke RL, et al. Mol Pharmacol. 2001 Dec;60(6):1365-74. doi: 10.1124/mol.60.6.1365. Mol Pharmacol. 2001. PMID: 11723244

10

Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).

Papke RL. Papke RL. J Pharmacol Exp Ther. 2002 May;301(2):765-73. doi: 10.1124/jpet.301.2.765. J Pharmacol Exp Ther. 2002. PMID: 11961083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters